Recon: Pharma lawsuit challenging Medicare drug price negotiations dismissed; BioAge raises $170M for obesity combo

Recon

ReconJason Scott

Biologics/ biosimilars/ vaccinesEuropeGlobalMedical DevicesNorth AmericaPharmaceuticalsRegulatory Intelligence/PolicyUnited States